Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 7:06 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1105–1128 of 1,600 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Skin Patch Clear all

Conditions: Transgenderism, Clotting Disorder
Interventions: Estradiol Tablets, Transdermal patch; Drug
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years and older · Male only
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Mental Disorder, Schizophrenia, Major Depressive Disorder, Bipolar I Disorder
Interventions: Placebo IEM tablet, Abilify MyCite®, D-Tect Patch; Drug · Device
Lead sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Garden Grove, California

Conditions: Post Operative Atrial Fibrillation
Interventions: CardiaMend with the Addition of Amiodarone; Combination Product
Lead sponsor: WakeMed Health and Hospitals; Other
Eligibility: 20 Years to 85 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Raleigh, North Carolina

Conditions: Restless Legs Syndrome
Interventions: Rotigotine; Drug
Lead sponsor: UCB BIOSCIENCES, Inc.; Industry
Eligibility: 13 Years and older
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 5
States / cities: Los Angeles, California • Orange, California • Spring Hill, Florida + 2 more

Conditions: Prostate Cancer
Interventions: Androderm® 2.5mg, Androderm® 5.0mg, Androderm® 7.5mg; Drug
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years and older · Male only
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Primary Ovarian Insufficiency
Interventions: Transdermal Estrogen; Drug
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 11 Years to 18 Years · Female only
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Sweat Rate
Interventions: Sweat patch; Other
Lead sponsor: PepsiCo Global R&D; Industry
Eligibility: 13 Years and older · Female only
Enrollment: 516 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Smoking
Interventions: Brief tobacco counseling; Behavioral
Lead sponsor: Oregon Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 2,637 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2009
U.S. locations: 3
States / cities: Jackson, Mississippi • New York, New York • Eugene, Oregon

Conditions: Menopause, Postmenopause, Premenopause, Cardiovascular Disease
Interventions: transdermal estradiol patch (Vivelle), oral estrogen (Estrace), progesterone (Prometrium); Drug
Lead sponsor: Northwestern University; Other
Eligibility: 47 Years to 55 Years · Female only
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1998 – 2005
U.S. locations: 2
States / cities: Chicago, Illinois • Seattle, Washington

Conditions: Contraception
Interventions: Gestodene/EE Patch (BAY86-5016); Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 1,502 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2010
U.S. locations: 63
States / cities: Birmingham, Alabama • Glendale, Arizona • Phoenix, Arizona + 54 more

Conditions: Nicotine Dependence
Interventions: Nicotine Patches, Denicotinized Cigarettes; Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 257 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Smoking Cessation
Interventions: Non-invasive vagus nerve stimulator plus nicotine replacement patches, nicotine replacement patches; Combination Product · Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Erythema, Edema
Interventions: "Chameleon" Personal Lubricant; Device
Lead sponsor: Church & Dwight Company, Inc.; Industry
Eligibility: 18 Years to 69 Years
Enrollment: 222 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016
U.S. locations: 1
States / cities: Union, New Jersey

Conditions: Normal Healthy Volunteers
Interventions: Degarelix, Testosterone, Anastrozole, Estrogen patch; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 60 Years to 80 Years · Male only
Enrollment: 43 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2018
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Carpal Tunnel Syndrome
Interventions: Study Device, Sham Device; Device
Lead sponsor: Pressure Profile Systems, Inc.; Industry
Eligibility: 21 Years to 65 Years
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 3
States / cities: Mission Viejo, California • Torrance, California • Cleveland, Ohio

Conditions: Sarcoidosis
Interventions: Habitrol, Placebo to Habitrol; Drug
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years to 75 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Diabetes Mellitus
Interventions: Finesse, Pen/Syringe (Usual injection device); Device
Lead sponsor: Calibra Medical, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 5
States / cities: San Francisco, California • Chicago, Illinois • Detroit, Michigan + 2 more

Conditions: Cancer
Interventions: Fluorescein; Drug
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2016
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Pediatric Sleep Disordered Breathing, Obstructive Sleep Apnea
Interventions: WatchPAT 400; Device
Lead sponsor: Milton S. Hershey Medical Center; Other
Eligibility: 6 Years to 18 Years
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Hummelstown, Pennsylvania

Conditions: Medical Device Complication, Brain Injuries, Brain Diseases, Stroke, Vasospasm
Interventions: conventional transcranial Doppler probe and wearable ultrasound patch.; Device
Lead sponsor: University of California, San Diego; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: San Diego, California

Conditions: Chronic Non-malignant Pain
Interventions: Buprenorphine transdermal patch, Placebo to match BTDS; Drug
Lead sponsor: Purdue Pharma LP; Industry
Eligibility: 18 Years and older
Enrollment: 267 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001
U.S. locations: 21
States / cities: Phoenix, Arizona • Trumbull, Connecticut • Clearwater, Florida + 17 more

Conditions: Skin Lesion, Melanoma (Skin), Mole
Interventions: Diagnostic Test; Other
Lead sponsor: Orlucent, Inc; Industry
Eligibility: 21 Years and older
Enrollment: 186 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 6
States / cities: Fremont, California • Irvine, California • Menlo Park, California + 3 more

Conditions: Fluid Intake in Athletes, Sweating Rate in Athletes, Sweat Chloride Concentration in Athletes
Interventions: Smart Cap, running and fitness exercisers only, Sweat Patch, all subjects- running, fitness, cycling, Reference sweat patch, all subjects - running, fitness, cycling, Bottle Scale, all subjects - running, fitness, cycling; Device · Other
Lead sponsor: PepsiCo Global R&D; Industry
Eligibility: 16 Years to 65 Years
Enrollment: 173 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 3
States / cities: Barrington, Illinois • Chicago, Illinois • Deer Park, Illinois

Conditions: Non-Melanoma Skin Cancers
Interventions: SM-020 1% Gel; Drug
Lead sponsor: DermBiont, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Charlotte, North Carolina

Search by objective public record fields.

Coagulation and Fibrinolysis of Estradiol in Transwomen

A Trial to Assess a Wearable Patch's Functioning to Detect Medication Ingestion

Prevention of Post-OP AFib Using Combination of CardiaMend and Amiodarone

Long-Term Follow-Up Study for Safety, Efficacy and Tolerability of Rotigotine in Adolescents With Restless Legs Syndrome

A Randomized Study of Testosterone Replacement in Patients With Low Risk Hormone Refractory Prostate Cancer

Primary Ovarian Insufficiency: Phenotype and Optimal Treatment

Normative Data for Sweating Rate, Sweat Sodium Concentration and Sweat Sodium Loss in Female Athlete

Tobacco Cessation Via Public Health Dental Clinics

Midlife Cholesterol Study

Study Investigating the Efficacy and Safety of a Contraceptive Patch for 13 Cycles

Extinction Based Treatment for Nicotine Dependence

A Study Of Vagal Nerve Stimulation In Conjunction With NRT For Smoking Cessation

Human Repeat Insult Patch Test to Evaluate Personal Lubricants

Impact of Estradiol Addback

Non-invasive CTS Device Clinical Trial

Nicotine Treatment for Pulmonary Sarcoidosis: A Clinical Trial Pilot Study

Feasibility Study of Finesse for Bolus Prandial Insulin Dosing Compared to Multiple Daily Injections

Fluorescein for Lymphatic Mapping and Sentinel Lymph Node (SLN) Biopsy in Patients With Stage I and II Malignant Melanoma

Pediatric/Adolescent WatchPAT 400 Reliability Pilot Study

Transcranial Doppler Using Wearable Ultrasound Patch

Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Nonmalignant Pain

Assessing Tissue Remodeling in the Skin Using SFI (Skin Fluorescence Imaging)

Validity of Smart Cap and Smart Sweat Patch

A Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratoses and Non-Melanoma Skin Cancers